GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 03/28/24
Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel DiseaseGlobeNewsWire • 03/21/24
GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 03/19/24
Jemperli Cancer Drug: What To Know As GSK Says It Improves Survival For Uterine Cancer PatientsForbes • 03/16/24
GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 03/14/24
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/13/24
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseBusiness Wire • 03/07/24
GSK's blood cancer drug meets main goal in late-stage trial; analysts tout comebackReuters • 03/07/24
GSK (GSK) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 03/01/24